Clinical Pharmacist Specialist: Formulary & Cost-Effectiveness

Presbyterian Healthcare Services; Albuquerque (NM); On-site; USD 100,000 - 176,000; Full time

Benefits offered by this job

Tuition reimbursement

Scholarship opportunities

Malpractice liability insurance

Loan forgiveness program

EPIC electronic charting system

Job summary

Presbyterian Healthcare Services in Albuquerque, NM is seeking a dedicated Clinical Pharmacist to manage the PHP pharmacy benefit, oversee prior authorization, formulary management, and regulatory compliance. You will collaborate with PMG and other providers to optimize prescribing and develop prescriber profiles using ICIS and predictive modeling tools.

The role emphasizes cost-effective drug utilization, education for members and providers, and contribution to drug initiatives and

Qualifications

• PharmD degree or NM Pharmacist license required.
• Residency or equivalent clinical experience preferred.
• Board certification desired.

Responsibilities

• Oversee formulary development and P&T committee decisions.
• Review discharge medications to prevent duplications and interactions.
• Engage in medication management clinics with providers and patients.
• Monitor PDL compliance and drug utilization patterns.
• Provide cost-effective prescribing recommendations to physicians.
• Develop disease management pathways and education programs.

Skills

Drug information

Cost-effective prescribing

Regulatory compliance

Patient safety

Education

PharmD or NM-licensed RPh

Residency or board certification preferred

Tools

ICIS

Predictive modeling tools

Job description

Presbyterian Healthcare Services in Albuquerque, NM is seeking a dedicated Clinical Pharmacist to manage the PHP pharmacy benefit, oversee prior authorization, formulary management, and regulatory compliance. You will collaborate with PMG and other providers to optimize prescribing and develop prescriber profiles using ICIS and predictive modeling tools.

The role emphasizes cost-effective drug utilization, education for members and providers, and contribution to drug initiatives and